Capricor therapeutics, inc. (CAPR)
Balance Sheet / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Dec'10
ASSETS
CURRENT ASSETS
Cash and cash equivalents

13,217

3,899

6,827

5,890

7,170

4,259

4,377

6,339

7,169

6,140

8,897

8,260

2,750

3,204

18,020

8,851

11,766

5,568

4,218

5,038

6,939

8,034

9,805

11,582

12,979

1,729

71

229

285

170

282

777

435

1,039

2,607

3,259

3,378

Marketable securities

0

5,986

0

0

0

2,997

5,994

5,995

5,995

7,984

4,997

3,998

8,992

12,990

2,499

2,499

2,498

7,999

12,999

15,494

15,483

0

325

325

326

326

-

-

-

4,192

-

-

-

-

-

-

-

Restricted cash

-

-

232

232

185

285

421

531

619

742

610

828

1,125

1,347

602

-

-

0

0

599

2,047

2,977

3,699

4,378

555

1,401

-

-

-

0

-

-

-

-

-

-

-

Grant receivable

118

87

101

144

122

204

172

287

306

344

537

312

197

223

1,163

218

303

211

403

380

746

360

259

-

-

0

-

-

-

767

-

-

-

-

-

-

-

Interest receivable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

25

-

-

-

-

-

-

-

Prepaid expenses and other current assets

433

571

129

375

425

724

426

388

522

501

190

239

398

342

118

239

321

210

92

130

202

235

105

123

169

222

37

60

112

38

155

164

220

271

420

379

219

Deferred financing fees

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

6

-

-

-

-

-

-

-

-

TOTAL CURRENT ASSETS

13,770

10,544

7,290

6,643

7,904

8,471

11,392

13,541

14,613

15,712

15,232

13,640

13,464

18,108

22,404

11,808

14,889

13,989

17,713

21,642

25,420

11,607

14,196

16,409

14,030

3,680

109

289

404

5,193

438

941

656

1,310

3,027

3,639

3,597

Furniture and equipment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

38

38

38

-

-

-

-

29

-

-

-

-

-

-

-

Laboratory equipment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

262

232

208

-

-

-

-

68

-

-

-

-

-

-

-

Leasehold improvements

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

23

23

-

-

-

-

-

-

-

-

-

-

-

-

-

Property, Plant and Equipment, Gross

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

325

294

247

-

-

-

-

98

-

-

-

-

-

-

-

Less accumulated depreciation

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

100

90

83

-

-

-

-

64

-

-

-

-

-

-

-

PROPERTY AND EQUIPMENT, net

410

442

474

506

541

574

622

507

535

372

394

399

411

435

351

355

344

318

332

263

253

229

224

204

163

74

0

0

1

33

4

6

7

9

10

12

16

OTHER ASSETS
Intangible assets, net of accumulated amortization of $254,269 and $253,187, respectively

5

6

17

28

38

49

60

71

82

93

105

117

130

142

154

166

178

191

203

215

227

239

288

248

228

257

-

-

-

178

-

-

-

-

-

-

-

Loan fees, net of accumulated amortization of $11,757 and $6,722 at September 30, 2014 and December 31, 2013, respectively

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

18

19

-

-

-

-

-

-

-

-

-

-

-

-

-

Loan fees, net of accumulated amortization of $8,556 and $6,722, respectively

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

28

-

-

-

-

0

-

-

-

-

-

-

-

In-process research and development, net of accumulated amortization of $0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,500

1,500

1,500

1,500

1,500

1,500

1,500

1,500

1,500

1,500

1,500

1,500

-

-

-

0

-

-

-

-

-

-

-

Other assets

107

119

124

128

132

151

157

207

157

95

61

61

61

61

61

61

71

70

133

69

69

55

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

55

55

25

25

-

-

-

18

-

-

-

-

-

-

-

Other noncurrent assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

4

4

9

-

-

51

51

-

51

51

51

Deposits

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

51

-

-

51

-

-

-

TOTAL ASSETS

14,293

11,113

7,907

7,306

8,617

9,247

12,232

14,327

15,388

16,273

15,793

14,218

14,068

18,747

24,471

13,892

16,984

16,069

19,882

23,690

27,471

13,632

16,282

18,437

15,976

5,537

114

294

415

5,423

495

1,000

716

1,372

3,090

3,704

3,665

LIABILITIES AND STOCKHOLDERS' EQUITY
CURRENT LIABILITIES
Accounts payable and accrued expenses

1,296

875

947

1,520

1,462

1,148

1,743

1,206

1,408

1,496

1,264

2,177

2,505

3,038

3,920

2,923

3,224

2,530

2,308

2,678

2,745

1,699

1,613

1,683

-

1,628

-

-

-

-

-

-

-

-

-

-

-

Accounts payable and accrued expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,518

-

-

-

-

264

-

-

-

-

-

-

-

Accounts payable and accrued expenses, related party

28

22

13

46

38

106

132

113

69

174

99

311

109

489

699

546

470

352

579

538

632

433

300

500

481

423

-

-

-

164

-

-

-

-

-

-

-

Loan payable, current

-

-

-

-

-

-

-

-

-

-

14,155

14,155

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accrued interest, current

-

-

-

-

-

-

-

-

-

-

1,167

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accounts payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

339

397

249

-

210

121

327

437

504

237

332

Accrued expenses and other current liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

497

346

202

-

69

108

59

64

177

161

652

Notes payable, net of unamortized discount of $123,204

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

326

258

190

-

-

-

-

-

-

-

-

Sub-award payable, related party

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

18

13

6

-

8

36

98

38

36

37

84

Sub-award payable, related party

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

75

-

-

-

-

-

-

-

Accrued royalties

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

111

142

132

-

-

-

-

24

-

-

-

-

-

-

-

Deferred revenue

-

-

-

-

-

-

-

-

-

-

0

0

683

1,367

2,050

2,734

3,645

3,645

3,645

3,645

4,166

4,166

4,166

4,166

4,166

0

-

-

-

-

-

-

-

-

-

-

-

TOTAL CURRENT LIABILITIES

1,324

897

960

1,566

1,500

1,255

1,876

1,320

1,477

1,670

16,688

16,644

3,299

4,895

6,670

6,204

7,340

6,528

6,534

6,863

7,545

6,299

6,192

6,492

6,299

2,052

1,181

1,015

649

529

287

267

485

541

717

436

1,069

LONG-TERM LIABILITIES
Deferred revenue, net of current portion

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

911

1,822

2,734

3,124

4,166

5,208

6,249

7,291

0

-

-

-

-

-

-

-

-

-

-

-

Loan payable

-

-

-

-

-

-

-

-

-

-

0

0

13,905

13,905

13,905

12,155

10,155

9,155

9,155

9,155

9,155

9,155

9,155

8,641

-

3,961

-

-

-

-

-

-

-

-

-

-

-

CIRM liability

3,376

3,376

3,376

3,376

3,376

3,376

3,376

3,376

3,376

3,376

3,376

3,100

3,100

3,100

3,100

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accrued interest

-

-

-

-

-

-

-

-

-

-

0

1,060

954

849

746

647

571

505

443

382

320

258

198

138

-

58

-

-

-

-

-

-

-

-

-

-

-

TOTAL LONG-TERM LIABILITIES

3,376

3,376

3,376

3,376

3,376

3,376

3,376

3,376

3,376

3,376

3,376

4,160

17,960

17,855

17,752

12,803

10,727

10,572

11,422

12,272

12,601

13,581

14,562

15,029

-

4,019

-

-

-

-

-

-

-

-

-

-

-

Loan payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3,961

-

-

-

-

0

-

-

-

-

-

-

-

Accrued interest

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

83

-

-

-

-

0

-

-

-

-

-

-

-

TOTAL LONG-TERM LIABILITIES

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

11,336

-

-

-

-

0

-

-

-

-

-

-

-

Warrant liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

499

512

408

-

180

190

-

0

-

-

-

TOTAL LIABILITIES

4,701

4,274

4,336

4,943

4,877

4,631

5,252

4,696

4,854

5,046

20,064

20,804

21,259

22,750

24,422

19,008

18,067

17,101

17,956

19,135

20,146

19,880

20,754

21,522

17,636

6,072

1,681

1,527

1,057

529

467

457

-

541

-

-

-

COMMITMENTS AND CONTINGENCIES (NOTE 6)

-

-

-

-

-

-

0

0

0

-

0

0

0

0

0

0

0

0

-

-

-

0

-

-

-

-

0

0

0

-

0

0

0

0

0

0

0

STOCKHOLDERS' EQUITY
Preferred stock, $0.001 par value, 5,000,000 shares authorized, none issued and outstanding

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

-

0

0

0

0

-

0

0

0

0

0

0

0

Preferred stock, $0.001 par value, 5,000,000 shares authorized, none issued and outstanding

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

Common stock, $0.001 par value, 50,000,000 shares authorized, 9,188,506 and 5,227,398 shares issued and outstanding, respectively

9

5

4

3

33

3

30

29

27

26

25

22

21

21

21

17

17

16

16

16

16

11

11

11

11

11

43

43

43

10

43

43

39

39

39

39

34

Additional paid-in capital

86,048

81,215

76,477

73,665

72,964

71,338

70,408

68,925

65,705

62,736

59,548

54,501

50,422

49,951

49,487

38,988

38,334

34,115

33,723

33,446

33,103

16,054

15,905

15,747

-

15,552

-

-

-

-

-

-

-

-

-

-

-

Additional paid-in capital

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

15,638

-

46,525

46,512

46,505

12,114

46,490

46,438

45,777

45,605

45,483

45,234

42,492

Subscription receivable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2

-

-

-

-

-

-

-

Accumulated other comprehensive income (loss)

0

-0

0

0

0

12

20

18

20

11

8

7

9

3

0

4

3

9

11

6

-3

0

-1

-0

-0

-0

-

-

-

-21

-

-

-

-

-

-

-

Accumulated deficit

-76,465

-74,380

-72,911

-71,304

-69,258

-66,738

-63,479

-59,342

-55,219

-51,547

-63,852

-61,117

-57,645

-53,979

-49,461

-44,127

-39,438

-35,172

-31,826

-28,914

-25,791

-22,315

-

-

-

-16,098

-48,136

-47,788

-47,190

-

-46,506

-45,939

-45,586

-44,814

-43,150

-42,006

-39,930

Deficit accumulated during the development stage

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

20,387

18,843

17,309

-

-

-

-

7,206

-

-

-

-

-

-

-

TOTAL STOCKHOLDERS' EQUITY

9,592

6,839

3,570

2,363

3,740

4,615

6,980

9,630

10,534

11,226

-4,270

-6,586

-7,191

-4,003

49

-5,116

-1,082

-1,031

1,925

4,555

7,324

-6,248

-4,471

-3,084

-1,659

-534

-1,567

-1,232

-642

4,894

27

542

230

830

2,372

3,268

2,596

TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY

14,293

11,113

7,907

7,306

8,617

9,247

12,232

14,327

15,388

16,273

15,793

14,218

14,068

18,747

24,471

13,892

16,984

16,069

19,882

23,690

27,471

13,632

16,282

18,437

15,976

5,537

114

294

415

5,423

495

1,000

716

1,372

3,090

3,704

3,665